Stem cell therapy in India has grown into one of the most researched areas of regenerative medicine, offering an additional option for patients living with chronic and degenerative conditions that have not responded well to conventional treatment. At StemCellCure, we help patients understand what stem cell therapy actually involves — in plain language — before they decide whether to explore it further.
Our approach is led jointly by two specialists: Dr. Prashant Tyagi, our Stem Cell Biotechnology Specialist, who oversees regenerative medicine protocol design, cell sourcing, and treatment planning; and Dr. B. N. Singh, our General Physician, who brings over three decades of clinical experience to the overall health evaluation of every patient. Together, they ensure that stem cell therapy is never offered as a standalone, one-size-fits-all procedure — it is built around a full assessment of each patient's medical history, current health, and diagnostic reports. This combination of specialised regenerative expertise and general medical oversight is central to how StemCellCure approaches patient safety, and it is why many patients — as well as referring doctors — choose to work with our team when exploring stem cell therapy in India.
Stem cells are the body's own repair cells, capable of developing into different specialised cell types. In regenerative medicine, stem cells — most commonly mesenchymal stem cells (MSCs) sourced from umbilical cord tissue — are introduced into the body to support tissue repair, reduce inflammation, and assist the body's natural healing response. This is different from conventional drug-based treatment, which typically manages symptoms rather than targeting the underlying tissue damage.
India has built strong regenerative medicine infrastructure over the past decade, combining experienced specialists, advanced laboratory processing standards, and significantly lower treatment costs than the US, UK, or Gulf countries. This combination has made India a preferred destination for both domestic and international patients exploring stem cell therapy.
| Neurological | Orthopaedic | Other Chronic Conditions |
|---|---|---|
| Spinal Cord Injury | Avascular Necrosis | Optic Nerve Atrophy |
| Cerebral Palsy | Knee Cartilage Defect | Chronic Liver Disease |
| Autism Spectrum Disorder | Rheumatoid Arthritis | Chronic Kidney Disease |
| Multiple Sclerosis | Non-Union Fracture | Diabetes |
Stem cell therapy is offered at StemCellCure as a medical practice under qualified specialist supervision, following individual case evaluation. It is important for patients to understand that stem cell therapy is not FDA-approved, is not a guaranteed cure, and outcomes vary by patient and condition. We believe informed decision-making — not overpromising — is central to ethical regenerative care.
Dr. Tyagi leads the regenerative medicine protocol design at Stem Cell Cure India, overseeing stem cell sourcing, lab processing, and treatment planning for every patient.
Dr. Singh brings over three decades of clinical experience in general medicine and surgery, supporting the overall health evaluation of patients — including baseline assessments for kidney disease patients — before and during their stem cell therapy journey at Stem Cell Cure India.
Yes. Stem cell therapy is offered as a medical practice under qualified specialist supervision, after individual case evaluation. It is not FDA-approved and outcomes vary.
Suitability depends on the specific condition, its stage, and prior treatment history. Our team reviews medical reports before confirming eligibility.
The terms are often used interchangeably. "Therapy" generally refers to the broader treatment approach and its clinical basis; for the step-by-step process of what happens during treatment, see our Stem Cell Treatment in India page.
